Reviva Pharmaceuticals Holdings, Inc. Unrecognized Tax Benefits that Would Impact Effective Tax Rate
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $1.70 million as of 2024-12-31, per its 10-K filed 2025-04-03.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2025-04-03
- 2024-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $1.70M.
- 2023-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $800.00K.
- 2022-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $100.00K.
- 2021-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $0.00.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate |
|---|---|
| 2024-12-31 | $1.70M 10-K · filed 2025-04-03 |
| 2023-12-31 | $800.00K 10-K · filed 2024-04-15 |
| 2022-12-31 | $100.00K 10-K · filed 2023-03-30 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-15 |
| 2019-12-31 | $0.00 10-K/A · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |